Reliq Health Technologies, Inc. Announces New Contract, Expansion into Clinical Trials Market – QNT Press Release

[ad_1]

HAMILTON, Ontario, March 24, 2022 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHTOTC:RQHTF) (“Reliq” or the “Company“), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed an agreement with a US Contract Research Organization to use its iUGO Care software and Patient Engagement services to support their oncology clinical trials.

“We are very excited to be moving into the clinical trials space,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. “The oncology clinical trial market alone is value at over $10 billion USD and is growing at over 5% per year. Using our iUGO Care platform and Patient Engagement services, Contract Research Organizations (CROs) can monitor trial-specific metrics such as medication adherence, side effects/safety and efficacy, and can also monitor existing comorbidities that must be tightly controlled during clinical trials such as hypertension, diabetes and other chronic conditions. We are very pleased to be working with our new client, a highly respected and experienced CRO that in the last year alone conducted over 1,000 clinical trials involving over …

Full story available on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center